SYNOPSIS Evidence is presented that after injection of radioactive vitamin B12 in man, there is a close correlation between the amount of radioactivity excreted and the amount of assayable vitamin B12 excreted, and thus that the amount of radioactivity excreted is a true measure of the vitamin B12 excreted. The possible reasons for this occurrence are discussed and it is suggested that in the body vitamin B12 does not exist as such but as an analogue or active derivative.
It is generally assumed that, in man, vitamin B12 (cyanocobalamin) is absorbed from the intestinal tract and functions in the body as an active substance without undergoing any chemical change. This view is based largely on the results of recovery experiments in which known amounts of vitamin B12 are added to tissues; the increase in microbiological activity, as measured by assay methods considered to be specific for vitamin B12, is proportional to the amount of added vitamin B12 and hence it seems likely that the original microbiological activity of the tissue is also due to vitamin B12.
If a patient who had no vitamin B12 in his body and was not excreting any radioactive substance in his urine were given an injection of radioactive vitamin B12 it would therefore be a reasonable assumption that the amount of radioactivity then found in the urine would be a true indication of the amount excreted via the kidney. For example, if this hypothetical patient were given 1,000 Mug. radioactive vitamin B12 intramuscularly and 20% of the radioactivity was found in the urine then that 20 % would represent 200 Mug. of vitamin B12. The normal subject, however, has between 1,500 and 5,000 Mug. of nonradioactive vitamin B12 in his body and the simple process outlined above cannot be assumed to occur because the possibility must be considered that the injected radioactive B12 might equilibrate or mix with the non-radioactive body stores. Under these circumstances the amount of radioactivity appearing in the urine after an injection of radioactive vitamin B12 would not be a true indication of the amount excreted but would represent only a fraction of that excreted. For example, if a patient with 3,000 Mg.
Received for publication 14 October 1960. non-radioactive vitamin B12 in his body were given 1,000 ug. radioactive vitamin B12 intramuscularly and 20% of the radioactivity was excreted in the urine then that 20% would represent 20% of (1,000 + a proportion of 3,000) microgrammes vitamin B12 depending on the completeness of equilibration.
Preliminary investigations showed that the normal subject excreted about 70% of the radioactivity of If equilibration did occur then the injected radioactive vitamin B12 would equilibrate with that remaining in the body from the previous injection. The use of control subjects would not only serve to reveal a constant error in the assay if such were present but would also reveal the degree of any equilibration which took place.
If it could be shown that equilibration of injected radioactive vitamin B12 and non-radioactive body stores of vitamin B12 did not occur then this finding would be of both practical and academic importance. Such a conclusion is drawn from the studies reported here.
PLAN OF THE EXPERIMENT
The object of the experiments was to compare the urinary excretion of radioactivity and of total assayable vitamin B12 after parenteral injection of M8Co vitamin B12 in normal subjects and control subjects who were suffering from vitamin B12 deficiency. To cover the usual range of doses used in clinical practical practice three different doses of 58Co vitamin B12 were used.
PATIENTS, MATERIALS, AND METHODS
The control patients were seven in-patients suffering from severe vitamin B12 deficiency. Five were diagnosed as having Addisonian pernicious anaemia on the basis of a macrocytic anaemia, megaloblastic bone marrow, histamine-fast achlorhydria, low serum vitamin B12 level, and a reticulocyte response and rise in peripheral blood values after treatirent with parenteral 58Co vitamin B12 only; after the study reported here the absorption of oral 58Co vitamin B12 was studied in these patients with and without intrinsic factor by the method of Schilling (1953) and the results supported the diagnosis. One patient was diagnosed as having adult coeliac disease on the basis of a macrocytic anaemia, nregaloblastic bone marrow, free gastric acid, excess fat in the faeces, a low serum vitamin B12 level, and reticulocyte response and rise in peripheral blood values after treatment with 58Co vitamin B12 only; Schilling tests on this patient showed malabsorption of vitamin B12 unaffected by the addition of intrinsic factor One patient came under observation with a macrocytic anaemia, megaloblastic bone marrow, and a low serum vitamin B12 level four years after total gastrectomy. He also responded to parenteral -8Co vitamin B12 and Schilling tests showed that he failed to absorb it unless it was given with intrinsic factor. The control patients were treated by 58Co vitamin B12 intramuscularly daily.
The normal patients were in-patients with a variety of diseases in which depletion of body vitamin B12 stores is not a known occurrence. All had normal serum vitamin B12 levels. These patients were given a single intramuscular injection of "8Co vitamin B12.
The nature and objects of the experiment were explained to the patients, all of whom cooperated willingly. 58Co vitamin B12 was obtained from the Radiochemical Centre, Amersham, and diluted to a concentration of 0 5 ug., specific activity 0-5 ,uc., in 5 ml. normal saline, dispensed in dark glass rubber-capped bottles, autoclaved and stored at + 4°C when not in use. The vitamin B12 content was checked by microbiological assay every week the batch was in use. Ampoules of 58Co vitamin B12 for injection were prepared in the three dose ranges by adding 2 ml. of the -8Co vitamin B12 solution to 1,140 and 540 ,tg. non-radioactive vitamin B12 and 3 ml. of the 58Co vitamin B12 solution to 54 itg. non-radioactive vitamin B12. The same tuberculin syringe was used for the preparation of these solutions and the preparation of the standard for isotope counting. Intramuscular injections were made by standard methods.
Urine was collected directly into acid-washed dark glass bottles. Pretreatment 24-hour collections were made on all patients. The total volume was noted and aliquots taken for isotope counting and microbiological assay. Samples for assay were diluted as required with vitamin B12-free water and stored at -20°C. till used: assays were performed as soon as possible.
ISOTOPIC METHODS The radioactivity in 450 ml. aliquots of urine contained in plastic bottles was measured by the end-on method in a suitably modified Ecko scintillation counter type N 550 with thallium-activated sodium iodide crystal, 3-81 cm. diameter and 2-54 cm. deep, shielded by 3 in. of lead, and an Ecko automatic scaler type N 530A. A standard containing 0-2 ,uc. 58 Co vitamin B12 and 2,000 itg. vitamin B12 as a carrier in 450 ml. water was used. All samples were counted until 10,000 counts had been recorded in the 1,140 pg. and 540 jug. series, or until 5,000 counts had been recorded in the 54 ,tg. series. MICROBIOLOGICAL ASSAYS were conducted by a modification of the methods of Ross (1952) and Hutner, Bach, and Ross (1956) Figs. 1, 2 , and 3. The essential statistical results are set out in Table I .
It will be observed that the mean results for excretion in the control and normal patients do not differ greatly. This aspect will be discussed in a further communication. DISCUSSION A clear implication of the results is that, for practical purposes, parenteral radioactive vitamin B12, in the doses used, does not equilibrate with the body stores of non-radioactive vitamin B12, at least in the 24 hours after injection. In the 54 ,ug. series it is permissible for the regression lines and standard devia- tion curves to be extended to meet the abscissa and ordinate. The lower SD curve for the control group (Fig. 1) lies on the point abscissaO, ordinate 0, while for the normal group the lower SD curve meets the ordinate at the point abscissa 0 ordinate -1-88, the regression line for the controls meets the ordinate at the point abscissa 0 ordinate 2-83 and the upper SD curve for the controls meets the ordinate at the point abscissa 0 ordinate 7 54. These findings are good evidence that the lack of equilibration occurs in the entire dose range up to 1,140 ,ug.
It is difficult to explain the phenomenon on the basis of the concept that vitamin B12 is present as such in man. An obvious explanation would be that the injected radioactive vitamin B12 is excreted so rapidly that there is insufficient time for equilibration to occur; detailed observations on the rate of excretion of injected 58Co vitamin B12 suggest that this explanation is unlikely to be wholly satisfactory.
The explanation may be related to the fact that the preponderant mass of vitamin B12 in the body is tissue bound. The process of binding involves at least physical changes, since the assayable vitamin B12 in liver is microbiologically active but is not dialysable, and it is pertinent to consider whether the process may not also involve chemical changes in the structure of the vitamin B12 molecule, i.e., whether vitamin B12 absorbed from dietary sources is converted to an analogue in the process of binding to body tissues. If this were the case one would not expect the injected radioactive vitamin B12 to equilibrate with the analogue until it also has been converted by the process of binding, by which time it would be fixed to the tissues and no longer free to be excreted. The proportion which is excreted would be that which the tissues have been unable to bind in the time available.
Recently biochemical evidence has been produced which suggests that a very considerable proportion of the cobalamins in rabbit liver are present not as vitamin B12 but as coenzymes which may be the metabolically active form of vitamin B12. There is also evidence that these coenzymes can be converted to vitamin B12 by procedures commonly used in microbiological assays of tissues such as exposure to heat, light, or to cyanide ions (Weissbach, Toohey, and Barker, 1959) . This suggests that in microbiological assays the substance which is actually measured is vitamin B12 derived from body stores of the microbiologically active form. In addition, one of these coenzymes, 5, 6-dimethylbenzimidazolylcobamide coenzyme, has been shown to be as metabolically active in patients with pernicious anaemia as vitamin B12 at the same dosage level (Wasserman, Estren, Brody, and Herbert, 1960) .
It is also clear from the results that when man is given such injections of radioactive vitamin B12 the radioactivity found in the urine in the subsequent 24 hours is a true indication of the amount of assayable vitamin B12 excreted and that this occurs regardless of its body stores. This finding is of considerable practical importance for it means that the isotope method can be used with confidence instead of the microbiological assay in determining the total urinary loss of vitamin B12 after an injection of radioactive vitamin B12, at least for the doses used. The isotope method, which makes use of a very small dose of radioactivity, has obvious advantages over the assay method; as a technical method it is inherently more accurate and reliable results may be obtained quickly and with little expenditure of time or labour. The practical application of this method will be dealt with in subsequent papers.
